Astrelis
Dialysis facility · West Burlington, IA

Southeastern Renal Dialysis, LC - W Burlington

CCN 162512Latest FY 2025
Cost-report basis
HCRIS · as filed
Not audited by Astrelis

Operating margin: +27.7% in FY2025, the 77th percentile of 7,109 dialysis facilities in the FY2025 pool. Days cash on hand: 94 days in FY2025, the 79th percentile of 1,453 dialysis facilities in the FY2025 pool. Total operating revenue: $3.0M in FY2025, the 38th percentile of 7,110 dialysis facilities in the FY2025 pool. Total margin (including nonoperating): +30.3% in FY2025, the 84th percentile of 7,110 dialysis facilities in the FY2025 pool. Figures as filed; not audited by Astrelis.

The read

A dialysis facility in West Burlington, IA. It ran an operating surplus of 27.7% in FY25 on $3.0M of operating revenue. It held 94 days of cash on hand (79th percentile of 1,453 dialysis facilities on liquidity, FY25 pool). 6 reporting years are on file, but revenue scale shifts too much between them for a comparable trend, so trend context is limited.

Operating margin · FY25
+27.7%
Astrelis calculation · as-filed inputs
vs dialysis facilities77th pctl of 7,109 (FY25 pool)
pool: this metric's own fiscal year · excludes historical, non-panel, and out-of-range values
Days cash on hand · FY25
94d
all sources
Astrelis calculation · as-filed inputs
vs dialysis facilities79th pctl of 1,453 (FY25 pool)
pool: this metric's own fiscal year · excludes historical, non-panel, and out-of-range values
Total operating revenue · FY25
$3.0M
Astrelis calculation · as-filed inputs
vs dialysis facilities38th pctl of 7,110 (FY25 pool)
pool: this metric's own fiscal year · excludes historical, non-panel, and out-of-range values
Total margin · incl. nonoperating · FY25
+30.3%
Astrelis calculation · as-filed inputs
vs dialysis facilities84th pctl of 7,110 (FY25 pool)
pool: this metric's own fiscal year · excludes historical, non-panel, and out-of-range values

Where Southeastern Renal Dialysis, sits among dialysis facilities

Operating margin · FY25 pool · n = 7,109 of 7,234 filed

Each point is one dialysis facility in the national FY25 distribution for this provider type, placed by operating margin. Facilities are not matched on size, case mix, or market; that is the matched-peer comparison in the paid benchmark. The dialysis facility FY25 median is +16.8%. Descriptive context only, not a ranking.

-20%-10%0%+10%+20%dialysis facility median +16.8%Southeastern Renal +27.7%
One dialysis facilitySoutheastern Renaldialysis facility median

The money

$ thousands · HCRIS cost-report basis · as filed, QA-gated

Ratios tell you how this dialysis facility is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio computes only when every input is reported in the filing (otherwise its cell states which input is Not reported in source); a year whose balance sheet does not reconcile is labeled, and its derived ratios read Astrelis calculation unavailable. Not audited by Astrelis.

Operating margin
+27.7% (FY25)
Operating income ÷ total operating revenue
Astrelis calculation · HCRIS WS G-3
Total margin
+30.3% (FY25)
Net income ÷ total revenue incl. nonoperating
Astrelis calculation · HCRIS WS G-3
Days cash on hand
94d (FY25)
Cash & investments ÷ daily operating expense
Astrelis calculation · HCRIS WS G / G-3
Current ratio
4.78× (FY25)
Total current assets ÷ current liabilities
Astrelis calculation · HCRIS WS G
Equity financing ratio
83% (FY25)
Total net assets ÷ total assets
Astrelis calculation · HCRIS WS G
Days in net patient A/R
413d (FY25) — outside expected range; computed from the filed statement and not ranked against peers
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
Astrelis calculation · HCRIS WS G / G-3
$ in thousands
Line itemFY23FY24FY25
Patient revenue8671,9372,992
Total operating revenue8671,9372,992
Total operating expenses1,8101,7472,164
Operating income(943)190828
Operating margin %-108.9%+9.8%+27.7%
Other non-operating, net7797112
Net income(867)286940
Net income %-91.9%+14.1%+30.3%
— = Not reported in source for that year.
HCRIS CMS-265 cost report · $ thousands · FY20–FY25 · operating revenue reflects net patient service revenue · FY20–21 may include COVID-era relief funding
Display states. FY23 · Operating margin: -108.9% — Astrelis calculation · outside expected range; shown at the chart boundary and included in peer statistics (beyond ±100%)

How it operates

quality & operational context · CMS public reporting

The metrics this dialysis facility type is judged on: care quality, patient experience, and scale. Each is labeled by provenance class and public source; descriptive context only, never a ranking or adequacy claim. Provenance labels: Reported value is copied from the named public source; Astrelis calculation is a formula applied to unchanged reported inputs, with the formula shown; Illustrative estimate is a benchmark gap, multiplier, or scenario — never a measurement.

Quality star
2★
Reported value2026
CMS Dialysis Compare
Total treatments
7,676
Reported value2025
HCRIS CMS-265
Cost per treatment ($)
281.91
Astrelis calculation2025
HCRIS CMS-265
Net revenue per treatment ($)
389.74
Astrelis calculation2025
HCRIS CMS-265
Dialysis stations
12
Reported value2026
CMS Dialysis Facility Compare
Modalities offered
In-center hemodialysis, Peritoneal dialysis
Reported value2026
CMS Dialysis Facility Compare

Trajectory

Cost-report basis · 6 reporting years
Operating margin
+22.5%+16.7%+14.0%-108.9%+9.8%+27.7%FY20FY21FY22FY23FY24FY25
Days cash on hand
470 days549 days460 days334 days230 days94 daysFY20FY21FY22FY23FY24FY25

State context

West Burlington, IA
Located in West Burlington, IA. County-level statistics: linkage not established — this record's county mapping is not verified in the resolved spine, and we never place a facility in a county by guesswork. State-level context appears here once a state aggregate layer lands.
Operating margin vs its peer poolFY25Astrelis calculation

27.7% operating margin — 77th percentile of 7,109 peers (FY25 pool).

The Board Briefing

What changed, what matters, and what your board should ask — every figure sourced to the public record.

Reserve The Board Briefing →
Performance Benchmark Report

($390 revenue vs $282 cost per treatment) = $108 per treatment above cost × 7,676 treatments ≈ $829K net spread at current volume · method
Reserve Performance Benchmark Report →
How we calculated this

Operating margin vs its peer pool: FY25 pool · n = 7,109.

Performance Benchmark Report: FY25 peer pool · n = 7,109 · conservative low band; acuity limits stated in the report.

Report coverage: Standard Facility Benchmark. 10 of 10 facility measures available from public sources. Every declared facility measure is available for this record, benchmarked against its same-year peer pools. The refund guarantee stands: if we cannot deliver the published scope, you pay nothing.

Portfolio Performance Review

A roster-priced triage of the per-facility benchmarks: every facility on your roster, benchmarked and sorted. Requires only a CCN roster.

From $7,500Founding Edition · built to order, first edition · priced by roster size · invoice after coverage confirmation · within 30 days
Request: scoped and quoted before any invoice. No payment is collected on this site.

Cite this page

release 2321a4fc37a7 · 2026-10-22

Astrelis Atlas, "Southeastern Renal Dialysis, Lc - W Burlington", https://astrelis.co/providers/dialysis/162512, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Machine-readable twin of this page: astrelis.co/providers/dialysis/162512.md (Markdown, the same figures with their fiscal years, pools and definitions). Last modified: release 2321a4fc37a7, 2026-10-22. Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.

build 2321a4fc37a7 · 2026-10-22 · dev